A Trial of Episil® Oral Liquid in Cancer Patients Suffering From Chemotherapy- and/or Radiation-induced Oral Mucositis
|
|
文献详情
编号/登记号：
注册时间：
研究开始时间：
研究结束时间：
项目类型：
本院角色：
多中心研究：
招募状态：
研究疾病/适应症：
研究类型：
研究单位：[1]Solasia Pharma K.K.[2]Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China河北医科大学第四医院[3]Tongji Hospital Wuhan, Hubei, China[4]Jiangsu Province Hospital Nanjing, Jiangsu, China[5]The People's Liberation Army 81 Hospital Nanjing, Jiangsu, China[6]The First Hospital of Jilin University Changchun, Jilin, China[7]Fudan University Shanghai Cancer Center Shanghai, Shanghai, China[8]The People's Liberation Army 307 Hospital Beijing, Beijing, China[9]Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
研究目的：
This is a randomized, multi-center, single-use, active-controlled, two-stage open study of episil®. The purpose of this study is to assess the local analgesic effect of episil® in cancer patients suffering from chemotherapy- and/or radiation-induced oral mucositis, which will provide scientific and reliable clinical data in the product registration in China.
